Verification evidence is still being completed.
Max Delbruck Center Berlin-Buch
Berlin, Germany
- Verified lead
- Prof. Dr. Maike Sander
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chair of the Board and Scientific Director
- 2026 technical specialization
- Biomedical Research, Genomics, Cell Engineering, and Translational Technology Platforms
- Review cycle
- May 2026
- Full address
- Robert-Rössle-Straße 10, 13125 Berlin, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Max Delbruck Center scientific directorate disclosure.
- Editorial note
- Biomedical research centre with 18 technology platforms, translational science partnerships, and a large Berlin-Buch innovation footprint.
Biomedical Research, Genomics, Cell Engineering, and Translational Technology Platforms
Good scientific practice framework, Technology-platform quality systems
Biomedical research centre with 18 technology platforms, translational science partnerships, and a large Berlin-Buch innovation footprint.
Biomedical research centre with 18 technology platforms, translational science partnerships, and a large Berlin-Buch innovation footprint.
- Lead
- Prof. Dr. Maike Sander (verified ↗)
- Address
- Robert-Rössle-Straße 10, 13125 Berlin, Germany (source ↗)
- Compliance
- GLP
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Large biomedical research centre
- Capabilities
- Disease biology research · Single-cell and omics platforms · Genome engineering
- Founded
- 1992
- Headcount
- 1001-5000
- Company page (open ↗)
Prof. Dr. Maike Sander
Chair of the Board and Scientific Director
Official Max Delbruck Center Berlin-Buch contact page naming Robert-Rössle-Straße 10 in Berlin.
Open sourceLarge biomedical research centre
Berlin, Germany. Biomedical Research, Genomics, Cell Engineering, and Translational Technology Platforms. Review completed on 15 Mar 2026.
Helmholtz Association and German biomedical research governance
Good scientific practice framework, Technology-platform quality systems
Biomedical Research, Genomics, Cell Engineering, and Translational Technology Platforms
Biomedical research centre with 18 technology platforms, translational science partnerships, and a large Berlin-Buch innovation footprint.
The Max Delbruck Center is a Berlin-Buch anchor with a formally disclosed scientific directorate and a large shared technology-platform base relevant to the cluster.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Max Delbruck Center Berlin-Buch located?
- Max Delbruck Center Berlin-Buch operates from Robert-Rössle-Straße 10, 13125 Berlin, Germany, Berlin, Germany.
- Who runs Max Delbruck Center Berlin-Buch?
- Max Delbruck Center Berlin-Buch is led by Prof. Dr. Maike Sander, Chair of the Board and Scientific Director. Verified 15 Mar 2026.
- What does Max Delbruck Center Berlin-Buch do?
- Biomedical research centre with 18 technology platforms, translational science partnerships, and a large Berlin-Buch innovation footprint. Core capabilities: Disease biology research, Single-cell and omics platforms, Genome engineering, Translational partnerships.
Related technical briefs
Briefs that name Berlin as a covered market or city.
